News summary

GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children

Source: ScienceDaily - Top Health • Published: 24 Sept 2026, 03:15

Summarized by Masters of Longevity from ScienceDaily - Top Health.

Pediatric health piece previewing a clinical study about GLP-1 medications and the risk of nutrient shortfalls in children, with discussion of monitoring and nutrition support.

GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
Key Takeaways
  • Nearly 1 in 6 pediatric patients developed a diagnosed nutritional deficiency within one year of starting GLP-1 therapy.
  • Vitamin D deficiency was the most common finding, affecting about 12% of children on GLP-1 drugs.
  • The study examined complications and the use of nutrition therapy or counseling alongside GLP-1 prescriptions in children.
Read the full article at ScienceDaily - Top Health ↗

Continue exploring

Recommended MoL Picks

MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?